Poehling Capital Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.95M | Sell |
201,459
-114,090
| -36% | -$1.1M | 0.46% | 53 |
|
2025
Q1 | $4.7M | Sell |
315,549
-9,255
| -3% | -$138K | 1.19% | 25 |
|
2024
Q4 | $4.85M | Buy |
324,804
+15,050
| +5% | +$225K | 1.19% | 23 |
|
2024
Q3 | $5.93M | Sell |
309,754
-3,344
| -1% | -$64K | 1.52% | 20 |
|
2024
Q2 | $6.48M | Sell |
313,098
-1,076
| -0.3% | -$22.3K | 1.77% | 15 |
|
2024
Q1 | $5.91M | Buy |
314,174
+1,314
| +0.4% | +$24.7K | 1.58% | 19 |
|
2023
Q4 | $4.51M | Sell |
312,860
-48,483
| -13% | -$699K | 1.43% | 23 |
|
2023
Q3 | $6.27M | Buy |
361,343
+3,519
| +1% | +$61.1K | 2.2% | 10 |
|
2023
Q2 | $7.45M | Buy |
357,824
+2,157
| +0.6% | +$44.9K | 2.52% | 7 |
|
2023
Q1 | $8.37M | Buy |
355,667
+47,903
| +16% | +$1.13M | 2.82% | 5 |
|
2022
Q4 | $8.6M | Sell |
307,764
-615
| -0.2% | -$17.2K | 3.22% | 4 |
|
2022
Q3 | $7.22M | Buy |
308,379
+16,862
| +6% | +$395K | 3.02% | 7 |
|
2022
Q2 | $9.84M | Sell |
291,517
-5,932
| -2% | -$200K | 3.7% | 4 |
|
2022
Q1 | $10.4M | Buy |
297,449
+19,664
| +7% | +$687K | 3.21% | 5 |
|
2021
Q4 | $8.46M | Buy |
277,785
+51,272
| +23% | +$1.56M | 2.73% | 8 |
|
2021
Q3 | $7.43M | Buy |
226,513
+105,043
| +86% | +$3.44M | 2.51% | 7 |
|
2021
Q2 | $3.68M | Buy |
+121,470
| New | +$3.68M | 1.17% | 27 |
|